Previously, colon organoids expanded from Lgr5+ stem cells were successfully transplanted into the colon epithelium36,37, and organoid transplantation into the gastrointestinal lumen is considered a potential future treatment option for patients with inflammatory bowel disease. Here, LGR5 is linked to inflammatory bowel disease.